Parkinsonism & Related Disorders
Volume 16, Issue 5 , Pages 338-344 , June 2010

Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus

  • Victoria E. Shaw

      Affiliations

    • Discipline of Anatomy & Histology F13, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia
    • ,
  • Kevin A. Keay

      Affiliations

    • Discipline of Anatomy & Histology F13, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia
    • ,
  • Keyoumars Ashkan

      Affiliations

    • Dept. of Neurosurgery, King's College Hospital, London, England, UK
    • ,
  • Alim-Louis Benabid

      Affiliations

    • Clinatec LETI-DTBS, CEA Grenoble, France
    • ,
  • John Mitrofanis

      Affiliations

    • Discipline of Anatomy & Histology F13, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 93512500.

Received 30 November 2009 ,Revised 15 February 2010 ,Accepted 16 February 2010.

References 

  1. Larsen J, Tandberg E. Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs. 2001;15:267–275
  2. Comella C. Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview. J Neural Transm Suppl. 2006;70:49–55
  3. Saper C, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001;24:726–731
  4. Lu J, Jhou TC, Saper CB. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci. 2006;26:193–202
  5. Chaudhuri KR, Schapira AHV. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464–474
  6. Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain. 2007;130:2129–2145
  7. Ma J, Shaw VE, Mitrofanis J. Does melatonin help save dopaminergic cells in MPTP-treated mice?. Parkinsonism Relat Disord. 2009;15:307–314
  8. Schooner A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004;318:215–224
  9. Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, et al. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared (NIr) light treatment. J Comp Neurol. 2010;518:25–40
  10. Paxinos G, Huang XF, Toga AW. The Rhesus monkey brain in stereotaxic coordinates. USA: Acad Press; 1998;
  11. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed.. California USA: Academic Press; 2001;
  12. Jacobowitz DM, Palkovits M. Topographic atlas of catecholamine and acetylcholinesterase containing neurons in the rat brain. I. Forebrain (telencephalon, diencephalon). II. Hindbrain (mesencephalon, rhombencephalon). J Comp Neurol. 1974;157:13–28
  13. Hirsch E, Graybiel AM, Agid YA. Melanised dopaminergic cells are differentially susceptible to degeneration in Parkinson disease. Nature. 1988;344:345–348
  14. Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, et al. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPP-intoxicated monkeys: effect of levodopa and GMl ganghoside therapy. Ann Neurol. 1994;36:206–214
  15. Flores JA, Galan-Rodriguez B, Ramiro-Fuentes S, Fernandez-Espejo E. Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in rewarding and sensitising properties of heroin. Neuropsychopharmacology. 2006;31:1475–1488
  16. Benarroch EE, Schmeichel AM, Dugger BN, Sandroni P, Parisi JE, Low PA. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia. Neurology. 2009;73:106–112
  17. Piallat B, Benazzouz A, Benabid AL. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci. 1996;8:1408–1414
  18. Kita H, Kitai ST. Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol. 1987;260:435–452
  19. Beart PM, Summers RJ, Stephenson JA, Cook CJ, Christie MJ. Excitatory amino acid projections to the periaqueductal gray in the rat: a retrograde transport study utilising D[3H]aspartate and [3H]GABA. Neuroscientist. 1990;34:163–176
  20. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscientist. 1989;32:213–226
  21. Benabid AL, Benazzouz A, Pollak P. Mechanisms of deep brain stimulation. Mov Disord. 2002;17(Suppl. 3):S73–S74
  22. Arnulf I, Bejjani BP, Garma L. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology. 2000;55:1732–1734
  23. Lyons KE, Pahwa R. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg. 2006;104:502–505

☆ The review of this paper was entirely handled by an Associate Editor, En-King Tan.

PII: S1353-8020(10)00046-5

doi: 10.1016/j.parkreldis.2010.02.008

Parkinsonism & Related Disorders
Volume 16, Issue 5 , Pages 338-344 , June 2010

Article Tools

* Image Usage & Resolution